Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,765 shares at $838.44 ($1.5M) on 2023-12-11, disclosed to the SEC on 2023-12-12.
Scheduled sale ($1.5M) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $843.79 | 852 | $719K | 48.4% |
| 2 | $838.44 | 270 | $226K | 15.2% |
| 3 | $838.44 | 270 | $226K | 15.2% |
| 4 | $844.09 | 373 | $315K | 21.2% |
| Total | $842.22 avg | 1,765 | $1.5M | 100% |
| Filing → |
| REGN | SELL | 2024-11-05 | $845K | — | Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |